Oxford-based pharmatech company uses artificial intelligence to find drug against COVID-19
Scientists at Oxford-based pharmatech company Exscientia are hoping to find a drug against COVID-19 within a year, using artificial intelligence technology.
In mid-March, they received a set of 12,000 de-risked drugs (drug molecules and molecules that have been checked for human safety) from the Calibr Institute based in California.
The lab has selected four different viral targets, which are proteins from the SARS-CoV-2 and are checking if they are affecting the molecules.
Scientific coordinator Aude Echalier says that it is essential to consider the "small molecule drug route" as a vaccine may never be found.
(Source: AFP)
Children risk 'generational catastrophe' from COVID: Watchdog
WHO in ‘imminent danger’ due to funding shortage: Top expert
‘New strain of coronavirus may have leaked from UK vaccine lab’
Iranian diaspora in EU, UK deplore ban on national airline
VIDEO | Press TV's News Headlines
Israel’s military struggling with shortage of troops: Report
Iran calls for more efforts to establish peace in Gaza, Lebanon
Israel targets journalists in southern Lebanon to mask atrocities
Trump vs Harris: A choice between two deranged war hawks who cheer genocide in Gaza
Over 1,800 Palestinians killed in Israel’s month-long attacks in northern Gaza
UN official urges Egypt to seize Israel-bound arms ship MV Kathrin
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
